Amazon Omics achieves FedRAMP Moderate authorization

[Amazon Omics](https://aws.amazon.com/omics/) has achieved Federal Risk and Authorization Management Program (FedRAMP) Moderate authorization for the AWS US East-West Regions. You can use Amazon Omics to store and process your data in AWS with up to the Moderate impact level. Amazon Omics is a fully managed service that helps healthcare and life science organizations build at-scale to store, query, and analyze genomic, transcriptomic, and other omics data. By removing the undifferentiated heavy lifting, customers can generate deeper insights from omics data to improve health and advance scientific discoveries. FedRAMP moderate authorization is available in all US Regions where Amazon Omics is generally available, which are currently US East (N. Virginia) and US West (Oregon). For more information, visit [Amazon Omics](https://aws.amazon.com/omics/) and for more information about FedRAMP, visit [Services in Scope](https://aws.amazon.com/compliance/services-in-scope/FedRAMP/).